PFIZER4,092.00

Pfizer Ltd.

· Pharma & Health
₹ CrorePeersGLAXOABBOTINDIAPOLYMEDONESOURCERAINBOWKIMSJUBLPHARMAVIJAYA
Comp Set
In ₹ Crore except Per Share
Latest Annual
PFIZER
FY26
GLAXO
FY26
ABBOTINDIA
FY26
POLYMED
FY26
Peer
Median
Valuation — at last close
P/E52.42×55.02×53.72×
P/B21.19×5.63×13.41×
EV/EBITDA35.08×39.06×37.07×
Market Cap₹48,417 Cr₹17,728 Cr₹33,073 Cr
Growth
Revenue CAGR 3Y1.29%5.53%9.01%18.91%9.01% -86%
Revenue CAGR 5Y2.39%3.62%9.96%18.98%9.96% -76%
Net Income CAGR 3Y5.01%19.26%17.80%21.39%19.26% -74%
Revenue YoY (latest Q)16.55%30.30%23.43%
Net Income YoY (latest Q)15.69%-8.39%3.65%
Profitability
EBITDA Margin35.88%34.26%27.31%23.59%27.31% +31%
Net Income Margin28.67%27.11%22.40%17.10%22.40% +28%
Return on Common Equity17.19%45.34%32.51%10.23%32.51% -47%
Return on Capital Employed19.71%48.84%36.14%9.78%36.14% -45%
Return on Assets14.68%23.96%23.87%8.18%23.87% -39%
Credit & Quality
Total Debt/Equity0.00×0.00×0.11×0.06× -100%
Interest Coverage89.28×455.22×72.67×17.87×72.67× +23%
Scale — latest FY
Revenue / Total Income₹2,520 Cr₹3,822 Cr₹6,929 Cr₹1,875 Cr₹3,822 Cr -34%
Net Income₹722 Cr₹1,036 Cr₹1,552 Cr₹321 Cr₹1,036 Cr -30%
Total Assets₹4,922 Cr₹4,324 Cr₹6,502 Cr₹3,919 Cr₹4,324 Cr +14%
EPS₹54.52₹0₹31.79₹31.79
Book Value per Share₹134.86₹310.7₹222.78
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.